Date Filed | Type | Description |
10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"TransMedics Completes Acquisition of Summit Aviation Andover, Mass. - August 16, 2023 - TransMedics Group, Inc. , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the closing of its previously announced acquisition of Summit Aviation, a premier U.S. charter flight operator. The acquisition enables the establishment of TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the U.S. “We are delighted to complete the acquisition of Summit Aviation, which represents a critical element of TransMedics' strategy to build and manage a national transplant logistics network designed to expand the reach and coverage of the Nat..." |
|
08/04/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
8-K
| Quarterly results |
08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/13/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/29/2023 |
8-K
| Credit agreement amendment |
05/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/11/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
05/09/2023 |
8-K
| Credit agreement amendment |
05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/01/2023 |
8-K
| Quarterly results |
05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/21/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/22/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
02/14/2023 |
SC 13G/A
| MACQUARIE GROUP LTD reports a 6.1% stake in Transmedics Group Inc. |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2023 |
SC 13G/A
| FMR LLC reports a 10.3% stake in TRANSMEDICS GROUP INC |
02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 5.3% stake in TransMedics Group Inc. |
02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/02/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/04/2022 |
8-K
| Quarterly results |
11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/03/2022 |
8-K
| Quarterly results |
08/08/2022 |
8-K
| Quarterly results |
08/05/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
|